GB PHARMA ApS: Financial statements 2025
CVR: 36054220
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.
- Revenue
- DKK 0
- Gross Profit
- DKK -10,000
- Profit/Loss
- DKK 31,613
- Equity
- DKK -1,902,842
- Total Assets
- DKK 80,982
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -10 t. | 32 t. | -1.9 mio. | 0 |
| 2024 | 42 t. | 33 t. | -5 t. | -1.9 mio. | - |
| 2023 | 22 t. | 12 t. | -31 t. | -1.9 mio. | - |
| 2022 | 43 t. | 33 t. | 65 t. | -1.9 mio. | - |
| 2021 | 0 | -10 t. | 3 t. | -2 mio. | - |
Official annual report
How creditworthy is GB PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
GB PHARMA ApS has published its annual report for 2024. Revenue came to DKK 42,457, and the net result was DKK -4,949.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.